Remix Therapeutics

Remix Therapeutics

  • Founded: 2019
  • Location: Cambridge, MA
  • Employee range: 50 - 200
  • Clinical stage: RD
  • Therapy area: Oncology
  • Drug types: ONC, NEU, GEN
  • Lead product: Undisclosed
  • Product link:
  • Funding: $70M B May 2022; $81M A Dec 2020
  • Investors: Surveyor, Foresite Capital, Atlas Venture, The Column Group, Arch Venture Partners, Alexandria Venture Investments, Casdin Capital

job board

Short description:

Small molecule therapies designed to reprogram RNA processing

Drug notes:

Additional undisclosed programs RD CNS diseases, genetic disorders, undisclosed

Long description:

Contact us to add description:


Remix Therapeutics
Senior Research Associate, Biology
Watertown, MA|29 days ago
Remix Therapeutics
Clinical Trial Manager, Clinical Operations
Watertown, MA|76 days ago

© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy